Ifp Advisors, Inc Regulus Therapeutics Inc. Transaction History
Ifp Advisors, Inc
- $3.28 Billion
- Q2 2025
Number of Shares
0Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RGLS
# of Institutions
7Shares Held
4.59MCall Options Held
0Put Options Held
25K-
Black Rock Inc. New York, NY3.97MShares$32.4 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE401KShares$3.27 Million6.25% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL85.6KShares$698,5120.0% of portfolio
-
Jpmorgan Chase & CO New York, NY74.5KShares$608,0580.0% of portfolio
-
Peak6 Investments LLC Chicago, IL60KShares$489,6000.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $119M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...